NCT00965419 A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder Status TERMINATED Phase PHASE2/PHASE3
NCT00962104 Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder Status COMPLETED Phase PHASE3
NCT00960986 A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT00960661 A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00958568 A Study in Relapse Prevention of Treatment-Resistant Depression Status COMPLETED Phase PHASE3
NCT00954915 Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis Status TERMINATED Phase PHASE1/PHASE2
NCT00954876 Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT00954447 Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00953862 Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility Status COMPLETED Phase NA
NCT00950365 Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00948675 Study of Participants With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00945945 A Study of Duloxetine in Patients With Osteoarthritis Knee Pain Status COMPLETED Phase PHASE3
NCT00935532 Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00934908 Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine Status WITHDRAWN Phase NA
NCT00933439 Assessment of Cognitive Functioning Before and After Treatment With Duloxetine Status COMPLETED Phase NA
NCT00927186 Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women Status COMPLETED Phase PHASE4